No connection

Search Results

CIB

BEARISH
$71.51 Live
Grupo Cibest S.A. · NYSE
Target $63.76 (-10.8%)
$39.89 52W Range $86.31

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 25, 2026
Market cap
$16.97B
P/E
9.05
ROE
17.0%
Profit margin
30.9%
Debt/Equity
N/A
Dividend yield
6.89%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
The deterministic health profile is critical, highlighted by a Piotroski F-Score of 0/9, indicating severe deterioration in financial fundamentals. While the stock has shown impressive long-term price appreciation and maintains a strong ROE of 16.96%, current growth metrics are catastrophic with YoY revenue down 80.10% and earnings down 72.30%. The stock is currently trading at $71.51, which is significantly above its growth-based intrinsic value of $55.30 and the analyst target price of $63.76. Despite an attractive dividend yield, the fundamental collapse outweighs the valuation appeal.

Key Strengths

Strong Return on Equity (ROE) of 16.96%
Attractive dividend yield of 6.89% with a sustainable payout ratio (54.24%)
Low P/E ratio (9.05) relative to the financial services sector average
Impressive long-term price performance (5Y Change: +305.8%)
Consistent history of earnings beats over the last 25 quarters

Key Risks

Catastrophic YoY revenue decline of 80.10%
Severe earnings contraction of 72.30% YoY
Piotroski F-Score of 0/9 signaling extreme financial weakness
Current price is trading at a premium to intrinsic value ($55.30)
Bearish technical trend (0/100) and negative short-term price momentum
AI Fair Value Estimate
Based on comprehensive analysis
$55.3
-22.7% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
43
Moderate
Value
45
Future
10
Past
85
Health
0
Dividend
75
AI Verdict
High Risk / Fundamental Collapse
Key drivers: Piotroski F-Score 0/9, Revenue Growth -80.10%, Price > Intrinsic Value
Confidence
90%
Value
45/100

Low multiples are likely a reflection of the growth collapse rather than a value opportunity.

Positives
  • Low P/E of 9.05
  • Low PEG of 0.43
Watchpoints
  • Price exceeds intrinsic value of $55.3
  • Price exceeds analyst target of $63.76
Future
10/100

Growth metrics are in a state of freefall.

Positives
No standout positives identified.
Watchpoints
  • Revenue growth -80.10% YoY
  • Earnings growth -72.30% YoY
  • Negative Q/Q revenue growth
Past
85/100

Historical performance is strong but decoupled from current fundamentals.

Positives
  • 305.8% 5-year return
  • Strong historical earnings surprise track record
Watchpoints
  • Recent quarterly earnings decline
Health
0/100

A 0/9 F-Score is a maximum red flag for financial health.

Positives
No standout positives identified.
Watchpoints
  • Piotroski F-Score 0/9
  • Lack of available Altman Z-Score data
Dividend
75/100

Strong current yield, but high risk of future cuts given earnings trends.

Positives
  • High yield of 6.89%
  • Moderate payout ratio of 54.24%
Watchpoints
  • Dividend sustainability is threatened by earnings collapse

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$71.51
Analyst Target
$63.76
Upside/Downside
-10.8%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for CIB and closest competitors.

Updated 2026-04-24
CIB
Grupo Cibest S.A.
Primary
5Y
+305.8%
3Y
+316.8%
1Y
+77.2%
6M
+29.8%
1M
-0.2%
1W
-3.2%
BSA
Banco Santander-Chile
Peer
5Y
+126.8%
3Y
+172.0%
1Y
+92.5%
6M
+54.5%
1M
+15.5%
1W
+8.6%
EWB
East West Bancorp, Inc.
Peer
5Y
+82.3%
3Y
+136.6%
1Y
+60.2%
6M
+22.7%
1M
+15.0%
1W
+1.4%
AFR
Affirm Holdings, Inc.
Peer
5Y
-42.4%
3Y
+368.3%
1Y
-0.0%
6M
-43.6%
1M
-17.1%
1W
-9.3%
IRE
IREN Limited
Peer
5Y
+89.7%
3Y
+1824.1%
1Y
+348.9%
6M
+451.4%
1M
-31.8%
1W
-25.7%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
9.05
Forward P/E
7.94
PEG Ratio
0.43
P/B Ratio
0.0
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
$16.97B

Profitability

Profit margins and return metrics

Profit Margin 30.91%
Operating Margin N/A
Gross Margin N/A
ROE 16.96%
ROA 1.89%

Growth

Revenue and earnings growth rates

Revenue Growth -80.1%
Earnings Growth -72.3%
Q/Q Revenue Growth -18.02%
Q/Q Earnings Growth -72.3%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$N/A

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$6051.9B
Net Margin
-30.6%
Total Assets
$379752.4B
Liabilities
$338756.7B
Equity
$39754.6B
Debt/Equity
8.52x
Operating CF
$6916.5B
CapEx
$-984.6B
Free Cash Flow
$5931.9B
FCF Yield
86%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-05-04
$N/A
2026-02-23
$1.77
-9.6% surprise
2025-11-06
$2.18
+21.4% surprise
2025-08-06
$1.79
+8.5% surprise

Financial Services Sector Comparison

Comparing CIB against 653 companies in the Financial Services sector (117 bullish, 269 neutral, 267 bearish)
P/E Ratio
9.05
This Stock
vs
38.75
Sector Avg
-76.6% (Discount)
Return on Equity (ROE)
16.96%
This Stock
vs
-0.94%
Sector Avg
-1911.2% (Below Avg)
Profit Margin
30.91%
This Stock
vs
58.65%
Sector Avg
-47.3% (Weaker)
Revenue Growth
-80.1%
This Stock
vs
42.21%
Sector Avg
-289.8% (Slower)

Similar Companies

Peer comparison within the same industry

SEC Filings

Recent regulatory filings from the SEC EDGAR database

20-F
20-F
2026-04-08

CIB filed its Form 20-F annual report on April 8, 2026, to provide comprehensive financial disclosures and risk assessments for the fiscal year. Specific financial highlights and risk factors were not provided in the available metadata.

Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
HOLD
11 analysts
UBS
2026-04-23
Maintains
Neutral Neutral
Itau BBA
2026-02-26
down
Market Perform Underperform
Goldman Sachs
2026-02-25
Maintains
Neutral Neutral
Citigroup
2026-01-22
down
Buy Neutral
Goldman Sachs
2026-01-13
up
Sell Neutral
JP Morgan
2025-11-21
Maintains
Neutral Neutral

Past News Coverage

Recent headlines mentioning CIB from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile